Opexa Therapeutics Presents Myelin Reactive T-Cell Research at the ...
Business Wire (press release) - San Francisco,CA,USA
Patient-specific T-cell lines for Tovaxin® vaccine formulation are then generated using synthetic peptides across myelin basic protein, proteolipid protein, ...
See all stories on this topic

Opexa Therapeutics presents Persistence of Myelin Reactive T-cells ...
RTT News - Williamsville,NY,USA
Patient-specific T-cell lines for Tovaxin vaccine formulation are then generated using synthetic peptides across myelin basic protein, proteolipid protein, ...
See all stories on this topic

The words no one ever wants to hear
Taunton Daily Gazette - MA, USA
Originally, my doctor was looking for symptoms of multiple sclerosis. Kennedy is a lucky man in that he has a loyal and very strong family. ...
See all stories on this topic

Posted by Jacob Goldstein
Wall Street Journal Blogs - New York,NY,USA
Ron Cohen, CEO of Acorda Therapeutics, talked with the Health Blog about the landscape for MS treatment and the prospects for Fampridine-SR, a medicine his ...
See all stories on this topic

MS Society Calls On MPs To Support New Avenues Of Research, UK
Medical News Today (press release) - UK
"At the moment, there are limited options for scientists investigating the use of stem cells and as a result, their full potential is yet to be realised. ...
See all stories on this topic

Invitrogen venture further into cell therapy with new unit
LabTechnologist.com - London,UK
Q Therapeutics develops cell-based therapies for a variety of central nervous system and neurodegenerative diseases, such as multiple sclerosis, ...
See all stories on this topic

They won't be brushed off
KeepMEcurrent.com - Scarborough,ME,USA
Those with the three more severe stages, called Primary-Progressive MS, Secondary-Progressive MS and Progressive-Relapsing MS, could steadily have more ...
See all stories on this topic

Health & Medicine
Investor's Business Daily (subscription) - USA
Privately held Bay Hill Therapeutics of Palo Alto, Calif. is attacking the same issue with a gene therapy approach. It also has some promise, Richert says. ...
See all stories on this topic

Troubled teens motivated by music
MiamiHerald.com - Miami,FL,USA
''For me, music is therapeutic,'' she said. ``It's powerful. If I'm having a bad day, the right song can completely change my mood. ...
See all stories on this topic

Tysabri

UPDATE 1-Elan says on track to meet profit, sales goals
Reuters - USA
The Dublin-based group also repeated it expected to make a profit in 2010 thanks to growing sales of its flagship multiple sclerosis (MS) drug Tysabri. ...
See all stories on this topic

Elan reaffirms core loss guidance, sees sales boost
Reuters - USA
DUBLIN, May 22 (Reuters) - Elan Corp (ELN.I: Quote, Profile, Research)(ELN.L: Quote, Profile, Research) Chief Executive Kelly Martin reaffirmed on Thursday ...
See all stories on this topic

Elan revenues in first quarter boosted by Tysabri MS drug; Loss ...
FinFacts Ireland - Ireland
By Finfacts Team Elan Corporation, today announced its first quarter 2008 financial results, which were boosted by Tysabri sales and provided a business ...
See all stories on this topic

Elan revenues boosted by Tysabri sales
Ireland Digital - UK
Elan Corp., the Irish drugmaker, yesterday announced its first quarter 2008 financial results, which were boosted by sales of the MS drug Tysabri. ...
See all stories on this topic

Elan aiming for profit by 2010 with Tsyabri sales
Irish Independent - Dublin,Ireland
By Sharon Lynch Elan said yesterday it expects to make a profit by 2010 and to reach its patient target for its multiple-sclerosis drug Tysabri by that year ...
See all stories on this topic

Elan CEO: Tysabri Use Accelerating From 26000 Patients In 1Q
CNNMoney.com - USA
PLC (ELN) Chief Executive Kelly Martin said the number of patients on multiple sclerosis drug Tysabri was "accelerating" from the 26000 patients recorded in ...
See all stories on this topic

neuroregeneration strategies

Astroglia: Not Just Glue
Journal of Neuropsychiatry (subscription) - USA
... Wahlberg L: Encapsulated cell biodelivery of GDNF: a novel clinical strategy for neuroprotection and neuroregeneration in Parkinson’s diseases? ...
See all stories on this topic

Vitamin D is Good for More Than Just Bones
RedOrbit - Dallas,TX,USA
We know that vitamin D helps the bones by preventing osteoporosis and fractures, but did you know that vitamin D also plays an important role in the ...
See all stories on this topic

Anti Inflammatory Medication May Treat Type 2 Diabetes
Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.

Healthcare Activists Plan June 19th As National Day Of Action Against Health Insurance Companies, California
Thousands to Gather in San Francisco and Around Country as 38,000 Insurance Industry Executives Meet for Annual AHIP ConventionNurses, Doctors, Patients, Consumer Activists Call for Guaranteed, Single-Payer Healthcare-"Patients Not Profits" Seeking an end to the healthcare crisis that is destroying American lives and families, thousands of healthcare activists will descend on San Francisco and on cities around the country this June 19th as part of an unprecedented national day of protests against health insurance corporations-and in support of guaranteed, single-payerhealthcare, the "Medicare for All" system succeeding in nearly every other industrialized democracy.

Anti Inflammatory Medication May Treat Type 2 Diabetes
Researchers at the Joslin Diabetes Center who reported earlier this year that an inexpensive, non-steroidal anti-inflammatory drug called salsalate might prevent type 2 diabetes are now reporting that the drug may also be beneficial in the treatment of the disease.

NARSAD Researchers Showcase New Treatment Options For Severe Depression; Provide New Clues About Treating Clinical Anxiety And Schizophrenia
New findings from research supported by NARSAD, the world's leading charity dedicated to mental health research, and conducted by scientists at Washington University's School of Medicine (WUSM) now point to new options for treating preschool-aged children with significant clinical depression as well as those severely depressed adults who don't respond to standard treatments, such as antidepressants and psychotherapy.